ESG406

· Shanghai Escugen Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ESG406, covering 2025-09-12 to 2025-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of ESG406 in Adults With Solid Tumors [Phase 1]